DCM
BHC icon

Driehaus Capital Management’s Bausch Health BHC Stock Holding History

Driehaus Capital Management’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-30,000
Closed -$70K – 549
2015
Q4 		$70K Buy
+30,000
New +$3.37M ﹤0.01% 510

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VH
ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Driehaus Capital Management's BHC Position: Q2 2021 in Review

Driehaus Capital Management sold out of Bausch Health (BHC) in Q2 2021, closing a stake of 464,895 shares — an estimated $14.8M sold.

Driehaus Capital Management first reported a position in BHC in Q3 2014 and held it in 7 quarters. The position peaked at $14.8M in Q1 2021. 357 funds tracked by Wall St. Rank hold BHC as of Q2 2021.

  • Driehaus Capital Management reported no remaining Bausch Health position as of Q2 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 464,895 Bausch Health shares in Q2 2021, an estimated $14.8M.
  • Driehaus Capital Management first reported a position in Bausch Health in Q3 2014 and held it in 7 quarters.
  • Driehaus Capital Management's Bausch Health position peaked at $14.8M in Q1 2021.
  • 357 funds tracked by Wall St. Rank held Bausch Health as of Q2 2021.

Based on Driehaus Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.